Business Description
AIM ImmunoTech Inc
NAICS : 325414
SIC : 2836
ISIN : US42366C3016
Description
Financial Strength
4/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 18.2 | |||||
Equity-to-Asset | 0.53 | |||||
Debt-to-Equity | 0.07 | |||||
Debt-to-EBITDA | -0.02 | |||||
Interest Coverage | N/A | |||||
Piotroski F-Score | 3/9 | |||||
Altman Z-Score | -32.71 | |||||
Beneish M-Score | -7.56 | |||||
WACC vs ROIC |
Growth Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -7.2 | |||||
3-Year EBITDA Growth Rate | -16.9 | |||||
3-Year EPS without NRI Growth Rate | -10.1 | |||||
3-Year FCF Growth Rate | -9.4 | |||||
3-Year Book Growth Rate | -48.7 |
Momentum Rank
5/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 24.37 | |||||
9-Day RSI | 35.72 | |||||
14-Day RSI | 41.88 | |||||
6-1 Month Momentum % | 2.03 | |||||
12-1 Month Momentum % | -9.46 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 1.68 | |||||
Quick Ratio | 1.68 | |||||
Cash Ratio | 1.51 | |||||
Days Sales Outstanding | 1590.1 | |||||
Days Payable | 22112.05 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -5.2 | |||||
Shareholder Yield % | -2.63 |
Profitability Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 79.21 | |||||
Operating Margin % | -15800.5 | |||||
Net Margin % | -14337.62 | |||||
FCF Margin % | -10473.94 | |||||
ROE % | -106.14 | |||||
ROA % | -91.19 | |||||
ROIC % | -616.3 | |||||
ROC (Joel Greenblatt) % | -2535.98 | |||||
ROCE % | -112.53 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PS Ratio | 107.05 | |||||
PB Ratio | 2.21 | |||||
Price-to-Tangible-Book | 2.89 | |||||
EV-to-EBIT | -0.32 | |||||
EV-to-EBITDA | -0.32 | |||||
EV-to-Revenue | 49.85 | |||||
EV-to-Forward-Revenue | 3.64 | |||||
EV-to-FCF | -0.47 | |||||
Price-to-Median-PS-Value | 0.66 | |||||
Price-to-Net-Current-Asset-Value | 4.18 | |||||
Price-to-Net-Cash | 5.37 | |||||
Earnings Yield (Greenblatt) % | -312.5 | |||||
FCF Yield % | -97.86 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
AIM ImmunoTech Inc Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil €) | 0.188 | ||
EPS (TTM) (€) | -0.555 | ||
Beta | 1.13 | ||
Volatility % | 53.26 | ||
14-Day RSI | 41.88 | ||
14-Day ATR (€) | 0.026953 | ||
20-Day SMA (€) | 0.44865 | ||
12-1 Month Momentum % | -9.46 | ||
52-Week Range (€) | 0.302 - 0.64 | ||
Shares Outstanding (Mil) | 50.75 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 3 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
AIM ImmunoTech Inc Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
AIM ImmunoTech Inc Stock Events
Event | Date | Price(€) | ||
---|---|---|---|---|
No Event Data |
AIM ImmunoTech Inc Frequently Asked Questions
What is AIM ImmunoTech Inc(STU:HXB2)'s stock price today?
When is next earnings date of AIM ImmunoTech Inc(STU:HXB2)?
Does AIM ImmunoTech Inc(STU:HXB2) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |